Treating disorders by application of insulin-like growth factors and analogs
AssigneeCephalon, Inc.
InventorsMichael E. Lewis, James C. Kauer, Kevin R. Smith, Kathleen V. Callison, Frank Baldino, Nicola Neff, Mohamed Iqbal
Life of this patent
Estimating the term…
Abstract
A method of enhancing the survival of neuronal cells in a mammal, the cells being at risk of dying, the method comprising administering to the mammal an effective amount of at least one of the following substances: IGF-I; a functional derivative of IGF-I; IGF-II; a functional derivative of IGF-II; IGF-III; or a functional derivative of IGF-III.
Claims2
A method of enhancing the survival of non-mitotic neuronal cells of the brain or spinal cord of a mammal, said cells being at risk of dying due to the effects of a neurological disease, head trauma or spinal cord injury on said neuronal cells, said method comprising administering to said mammal an effective amount of insulin-like growth factor-II.
Dependencies are inferred from the claim text.